In phase one of the study, hospitalized COVID-19 patients are being dosed at medical facilities to closely track safety and response to the treatment, with initial results expected in about one month.

Indianapolis-based Eli Lilly and Company announced Monday that patients have been dosed in the world's first study of a potential antibody treatment designed to fight COVID-19.

The Lilly Insulin Value Program covers most insulins made by the drug maker and is available to those with or without insurance.

The number of COVID-19 tests available in Indiana is steadily increasing, according to state health officials, but testing services remain limited to select groups of people.

Indianapolis-based Eli Lilly and Company Tuesday expanded free COVID-19 testing to first responders in addition to health care workers.

Eli Lilly is now offering drive-through testing for the virus that causes COVID-19 for Indianapolis health care workers.

The number of people being tested for the coronavirus has been limited by national shortages in tests and days-long waits for results. Two companies in Indiana are working to increase public testing.

A new partnership financed by memorial funds endowed by Eli Lilly and Co.'s first black chemist has set its sights on preserving some of Indiana's significant African American landmarks.

There is already a $16.5 million commitment from local philanthropic groups, including $15 million from the Lilly Endowment.

The Commerce Department says the North Carolina location beat out Indianapolis and Philadelphia for the plant, which will in part produce injectable drugs to treat diabetes.